ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3080 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3080; 2) Community: the network communities that were significantly associated with the response to NSC 3080; 3) Molecule: the relationships between components within communities and NSC 3080; 4) MDR: the compounds that were significantly associated with the NSC 3080.

NSC Compound Enrichment Correlation
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0352786308082227 0.18364993
NSC 716223 Null 0.0352786308082227 0.051148372
NSC 126728 WLN: T B-18-56 C6 A 2BC D& AX CX EOV KOV QVO VO MU OU A&UTJ B1 GQH1 B&1 A-& BT3OX CHJ 0.0352786308082228 0.33097028
NSC 135037 Jatrophone 0.0352786308082228 0.10925049
NSC 109834 Null 0.0415729612483928 0.48825237
NSC 119875 Cisplatin 0.0415729612483928 0.33506798
NSC 139105 Soluble Baker's Antifol 0.0415729612483928 0.51682849
NSC 144055 Picolinaldehyde, 5-hydroxy-, thiosemicarbazone, acetate (ester) (8CI) 0.0415729612483928 0.26771325
NSC 163088 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride (9CI) 0.0415729612483928 0.14514726
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0415729612483928 0.27272575
Total:72  Current:53    [First] [Prev] [Next] [Last]